Strategies for preventing neonatal group B streptococcal disease.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000891:Anti-Infective Agents, Local / Q000494:pharmacology; D001428:Bacterial Vaccines / Q000276:immunology; D003428:Cross Infection / Q000517:prevention & control; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D011135:Polysaccharides, Bacterial / Q000276:immunology; D011247:Pregnancy; D012306:Risk; D013290:Streptococcal Infections / Q000276:immunology / Q000517:prevention & control*; D013292:Streptococcus agalactiae; D014621:Vagina / Q000382:microbiology
D000900:Anti-Bacterial Agents; D000891:Anti-Infective Agents, Local; D001428:Bacterial Vaccines; D011135:Polysaccharides, Bacterial; C032263:streptococcal polysaccharide type III group B